Status:
UNKNOWN
The Effectiveness of Albendazole Treatment Among Infected Toxocara Children
Lead Sponsor:
Pham Ngoc Thach University of Medicine
Collaborating Sponsors:
Department of Science and Technology, Ho Chi Minh City, Viet Nam
Conditions:
Toxocara Infection
Eligibility:
All Genders
3-15 years
Phase:
NA
Brief Summary
This study consists 2 phases. The first phase will conduct a cross-sectional study to determine the infection rate of Toxocariasis larvae, describe the clinical and paraclinical characteristics, ident...
Detailed Description
This study includes 2 phases below: Phase 1: Cross-sectional study Sample population: total 960 pupils aged 3-15 years old from public kindergartens, primary schools, and secondary schools in Ho Chi ...
Eligibility Criteria
Inclusion
- Inclusion Criteria for phase 1 study:
- Pupils aged 3-15 years from Kindergarten to Secondary schools
- Agreement from parents with writen informed consent
- Inclusion criteria for intervention:
- Children infected with toxocariasis may have symptoms and the ELISA test is positive for Toxocariasis larvae, with or without increased BCAT and IgE.
- ELISA results according to the specified Kit and read according to optical densities (OD).
- Cases of suspected heart, lung, liver, eye damage ... referred to Children's Hospital 2 for examination by specialty and not for intervention.
- Exclusion Criteria:
- Children aged 3-15 years without writen informed consent from parents and themselves.
- Children infected with Toxocariasis larvae which are not common type.
- Children infected with Toxocariasis are suffering from acute diseases or other chronic diseases: Cardiovascular, hepatitis, kidney, stomach, mental, or suspected tumor...
- Children with a history of hypersensitivity to any ingredient in the treatment of Albendazole.
- Infected children do not have enough follow-up process before and after 1, 6 months of treatment.
Exclusion
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
960 Patients enrolled
Trial Details
Trial ID
NCT05208333
Start Date
May 1 2022
End Date
March 1 2024
Last Update
April 20 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.